What Is Going on With Avenue Therapeutics (ATXI) Stock Today?
What Is Going on With Avenue Therapeutics (ATXI) Stock Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股票市場新聞、股票建議和交易提示
Avenue Therapeutics (NASDAQ:ATXI) stock is seeing wild movement on Friday following a reverse stock split and regulatory update.
大道治療公司納斯達克股票代碼：ATXI)股票週五在反向股票拆分和監管更新後出現瘋狂波動。
Starting with that reverse stock split, the company consolidated 15 shares of ATXI stock into a single share. This boosts the price of the company's stock, which helps it avoid the delisting of its shares from the Nasdaq Exchange.
從股票反向拆分開始，該公司將ATXI股票的15股合併為一股。這提振了該公司股票的價格，這有助於其避免其股票在納斯達克交易所退市。
ATXI stock was previously in danger of being delisted from the Nasdaq due to its price being below $1 per share. This had it trading at around 20 cents per share prior to the reverse stock split. Following the split, shares are trading at around $4.20 as of this writing.
此前，由於股價低於每股1美元，ATXI股票有被納斯達克摘牌的危險。這使得它在反向股票拆分之前的交易價格約為每股20美分。拆分後，截至撰寫本文時，該公司股價約為4.20美元。
With that reverse stock split in effect, Avenue Therapeutics also decreased the total amount of outstanding shares. Now its outstanding shares are sitting at 1.5 million, as compared to its prior 22.7 million shares outstanding.
隨着反向股票拆分的生效，Avenue治療公司也減少了流通股總數。現在它的流通股為150萬股，而之前的流通股為2270萬股。
Regulatory Update
法規更新
Avenue Therapeutics also got the minutes from a meeting with the U.S. Food and Drug Administration (FDA). This covers concerns the FDA had about the company's IV Tramadol product candidate.
Avenue Treeutics還從與美國食品和藥物管理局(FDA)的一次會議上獲得了會議紀要。這包括FDA對該公司靜脈注射曲馬多候選產品的擔憂。
Avenue Therapeutics notes that it intends to use the comments from the FDA to address concerns. This will have it submitting a study protocol that could lay the groundwork for a complete response to the FDA.
Avenue治療公司指出，它打算利用FDA的評論來解決人們的擔憂。這將使其提交一份研究方案，為全面迴應FDA奠定基礎。
As of this writing, some 4 million shares of ATXI stock are on the move. That's already well above its daily average trading volume of about 2.2 million shares.
截至撰寫本文時，約有400萬股ATXI股票在移動中。這已經遠遠高於其約220萬股的日均成交量。
ATXI stock is down 37% as of Friday morning following a massive rally yesterday.
ATXI的股價在昨日大幅上漲後，截至週五上午下跌了37%。
There's more recent stock market news worth checking out below!
下面有更多最新的股市新聞值得一看！
We've got all of the hottest stock news traders need to know about for Friday! That includes why shares of Sonendo (NYSE:SONX), Cano Health (NYSE:CANO), and chip stocks are on the move today. You can find out more on these matters at the following links!
我們有所有交易員週五需要知道的最熱門的股票新聞！這包括為什麼索南多(紐約證券交易所代碼：SONX)，卡諾健康(紐約證券交易所：卡諾)，芯片類股今日走勢。您可以在以下鏈接中找到有關這些問題的更多信息！
More Friday Stock Market News
更多週五股市新聞
- Why Is Sonendo (SONX) Stock Up 15% Today?
- CANO Stock Moves as Humana, CVS Consider Acquisition
- Why Are Chip Stocks NVDA, AMD, INTC Down Today?
- 為什麼Sonendo的股票今天上漲了15%？
- Cano股價走勢，Humana，CVS考慮收購
- 為什麼芯片股NVDA，AMD，INTC今天下跌？
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版日期，威廉·懷特沒有(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點，以InvestorPlace.com為準出版指南.
The post What Is Going on With Avenue Therapeutics (ATXI) Stock Today? appeared first on InvestorPlace.
帖子今天大道治療公司(ATXI)的股票怎麼了？最先出現在InvestorPlace上。